This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Use of rasagiline
PDMED_RASAGILINE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
890 |
4. Check minimum number of events
Min. number of events
3
|
890 |
5. Include endpointsNone |
890 |
6. Filter based on genotype QC (FinnGen only) |
872 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
Use of rasagiline
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 872 | 398 | 474 |
| Unadjusted period prevalence (%) | 0.18 | 0.14 | 0.22 |
| Median age at first event (years) | 65.79 | 65.58 | 65.97 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 890
- Matched controls
- 8900
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N04BB01
ATC
amantadine; oral
53.3
313.8
183
43
N04BD01
ATC
selegiline; oral
693.9
307.7
636
32
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
1627.4
307.7
859
149
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
549.5
307.7
549
26
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
5846.7
307.7
878
110
N87
ICPC
Parkinsonism
210.0
307.7
500
54
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
182.5
307.7
164
11
N04BC04
ATC
ropinirole; oral
348.0
307.7
422
23
N04BD02
ATC
rasagiline; oral
+∞
307.7
890
5
G20
ICD-10 Finland
Parkinson disease
9842.4
307.7
884
119
193
Kela drug reimbursment
Rasagiline
8294.5
307.7
706
*
N04BC05
ATC
pramipexole; oral
49.1
307.7
621
400
N04BC09
ATC
rotigotine; transdermal
486.9
227.6
218
6
N06DA03
ATC
rivastigmine; oral, transdermal
12.2
183.6
205
213
R25.1
ICD-10 Finland
Tremor, unspecified
16.3
177.7
161
119
N03AE01
ATC
clonazepam; systemic
10.3
169.1
215
266
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
64.8
167.8
93
16
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
239.6
157.6
158
8
N04BX02
ATC
entacapone; oral
452.5
156.5
152
*
N04AA02
ATC
biperiden; systemic
22.3
138.8
105
53
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
28.8
133.5
91
35
G04BD12
ATC
mirabegron; oral
5.8
132.1
324
794
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
203.5
120.8
123
7
N05AH04
ATC
quetiapine; oral
5.4
119.3
316
820
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
31.4
113.6
75
26
XA800
NOMESCO Finland
Neuropsychological investigation
10.2
108.6
131
148
N04BX04
ATC
opicapone; oral
348.5
93.8
93
*
N19
ICPC
Speech disorder
17.0
80.3
68
43
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
14.9
75.7
69
50
H02AA02
ATC
fludrocortisone; oral
21.7
75.5
57
28
R4130
NOMESCO Finland
Speech therapy
10.7
74.2
84
86
AA1AD
NOMESCO Finland
CT of head and brain
3.4
68.6
432
1951
SPAT1215
SPAT
Assessment of need for medical rehabilitation
7.0
67.0
110
177
SPAT1229
SPAT
Assessment of need for aid
4.7
63.8
168
417
L28
ICPC
Limited function/disability (L)
3.5
62.7
301
1141
R1250
NOMESCO Finland
Evaluation of functional capability
9.5
61.3
75
85
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.4
59.1
172
460
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.7
59.1
157
391
C07AA05
ATC
propranolol; systemic
3.3
54.1
269
1030
I95.1
ICD-10 Finland
Orthostatic hypotension
5.7
50.6
101
196
A28
ICPC
Limited function/disability NOS
3.0
47.4
275
1140
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
6.9
46.7
75
117
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
62.5
45.9
53
9
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
4.4
45.2
126
323
R35
ICD-10 Finland
Polyuria
4.1
44.5
135
369
Z2445
NOMESCO Finland
Psychologist
6.7
43.0
71
114
XF606
NOMESCO Finland
Ortostatic test
15.4
41.9
37
25
N06AX11
ATC
mirtazapine; oral
2.6
41.6
398
2112
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.5
39.1
388
2080
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.8
39.0
268
1201
SPAT1231
SPAT
Assessment of adjustments needed in living environment
7.4
39.0
58
83
R1260
NOMESCO Finland
Evaluation of communicative skills
8.1
38.6
53
69
D21
ICPC
Swallowing problem
8.6
37.5
49
60
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.8
35.6
230
993
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
187.3
35.0
36
*
R53
ICD-10 Finland
Malaise and fatigue
2.5
33.7
282
1378
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.0
33.4
102
278
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.4
33.3
376
2100
N04BC06
ATC
cabergoline; oral
49.5
31.8
38
8
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.7
31.4
110
330
R47.1
ICD-10 Finland
Dysarthria and anarthria
8.1
30.0
41
53
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.7
29.8
201
879
SPAT1216
SPAT
Assessment of functional ability
2.5
28.4
224
1054
K59.09
ICD-10 Finland
Constipation, unspecified
3.4
28.2
112
364
SPAT1234
SPAT
Support of social functional capacity
3.9
27.4
87
243
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
64.1
27.1
31
5
N05BA04
ATC
oxazepam; oral
2.3
26.5
284
1523
U04
ICPC
Incontinence urine
3.6
26.4
93
279
N04BC07
ATC
apomorphine; parenteral
+∞
26.2
25
*
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
5.6
26.2
51
96
N28
ICPC
Limited function/disability (N)
6.3
26.1
45
75
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.4
26.1
100
317
N03AX12
ATC
[U] gabapentin; oral
2.4
26.0
215
1030
N04BC02
ATC
pergolide; oral
268.0
25.8
26
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.8
24.9
139
548
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
44.2
24.7
30
7
N29
ICPC
Neurological sympt/complt other
5.8
24.7
46
83
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
9.3
24.0
29
32
N06AB10
ATC
escitalopram; oral
2.4
23.0
190
904
A06AD11
ATC
lactulose; oral
2.4
22.9
189
899
S01.0
ICD-10 Finland
Open wound of scalp
2.9
22.8
117
440
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.3
22.3
196
957
JDB10
NOMESCO Finland
Percutaneous gastrostomy
6.8
22.3
35
53
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.8
22.1
124
489
AAW01
NOMESCO Finland
Implantation of intracranial stimulation device
+∞
22.0
21
*
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
3.5
21.8
80
246
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.2
21.1
89
299
R60.0
ICD-10 Finland
Localized oedema
2.4
20.9
160
734
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.4
20.6
157
718
M48.0
ICD-10 Finland
Spinal stenosis
2.3
20.3
178
866
XKD06
NOMESCO Finland
Physiologic investigation of micturition
4.1
20.2
57
146
Z50.5
ICD-10 Finland
Speech therapy
8.2
20.1
27
34
XKD00
NOMESCO Finland
Uroflowmetry
2.2
20.0
218
1158
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
21.4
20.0
29
14
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.8
19.9
107
412
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.8
19.8
106
407
G02CB01
ATC
bromocriptine; systemic
7.9
19.6
27
35
F02.30
ICD-10 Finland
Dementia in Parkinson's disease without additional symptoms
204.4
19.6
20
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
5.6
19.1
37
69
W19
ICD-10 Finland
Unspecified fall
2.6
18.7
122
517
M54.5
ICD-10 Finland
Low back pain
1.9
18.6
346
2218
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.5
18.4
45
103
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
7.8
17.9
25
33
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
17.8
191
1005
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
4.1
17.7
49
124
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
6.5
17.2
28
44
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.2
16.9
169
863
R5110, ,
SPAT
2.8
16.8
91
351
AA5QN, ,
NOMESCO Finland
+∞
16.7
16
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.1
16.3
185
992
R23
ICPC
Voice symptom/complaint
4.8
16.2
37
80
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
17.1
16.1
25
15
M41.9
ICD-10 Finland
Scoliosis, unspecified
6.1
16.1
28
47
G04BD11
ATC
fesoterodine; oral
4.0
16.1
46
119
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.6
15.9
99
410
N30.0
ICD-10 Finland
Acute cystitis
2.2
15.8
156
791
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
7.4
15.7
23
32
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
16.4
15.3
24
15
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
4.9
15.3
34
72
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
18.1
15.2
23
13
A04
ICPC
Weakness/tiredness general
2.1
15.1
154
791
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.8
15.0
77
288
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
5.6
14.8
28
51
XKC03
NOMESCO Finland
Water cystometry
3.7
14.5
47
133
UKC02
NOMESCO Finland
Cystoscopy
2.0
14.5
195
1108
AA1AA
NOMESCO Finland
Head X-ray examination
6.1
13.9
24
40
H50.52
ICD-10 Finland
Exophoria
6.6
13.7
22
34
N30.9
ICD-10 Finland
Cystitis, unspecified
2.8
13.5
69
258
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
18.6
13.4
20
11
G04BD09
ATC
trospium; oral
3.8
13.3
41
112
G04BD08
ATC
solifenacin; oral
2.5
13.2
90
388
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
40.7
13.2
16
*
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
6.2
13.0
22
36
K59.0
ICD-10 Finland
Constipation
2.7
12.9
70
270
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.0
12.8
58
203
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
3.5
12.7
45
135
K02.1
ICD-10 Finland
Caries of dentine
1.7
12.7
486
3716
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.5
12.7
84
358
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.4
12.6
96
435
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.8
12.6
63
233
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
3.9
12.4
37
99
N03AX16
ATC
[U] pregabalin
1.8
12.3
237
1502
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
12.1
130
677
R33
ICD-10 Finland
Retention of urine
2.2
12.0
102
485
S72.0
ICD-10 Finland
Fracture of neck of femur
3.0
11.8
54
190
R4110, ,
SPAT
2.2
11.7
105
510
N04BC01
ATC
bromocriptine; oral
65.8
11.6
13
*
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
5.3
11.6
23
44
Z3226
NOMESCO Finland
Physiotherapist
1.8
11.5
187
1121
F0230, G20,
ICD-10 Finland
+∞
11.5
11
*
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
10.7
11.3
21
20
R1250, ,
SPAT
4.5
11.3
27
61
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.3
11.2
88
404
N02BE01
ATC
paracetamol; systemic, rectal
2.3
11.2
811
7291
Z50.1
ICD-10 Finland
Other physical therapy
2.6
11.2
68
278
SPAT1172
SPAT
Guidance concerning hydration
4.0
11.1
31
79
TKC22
NOMESCO Finland
Catheterisation instruction
3.4
11.1
39
117
J01EA01
ATC
trimethoprim; systemic
1.7
11.1
229
1475
R60.9
ICD-10 Finland
Oedema, unspecified
2.6
11.0
66
268
M54.4
ICD-10 Finland
Lumbago with sciatica
1.9
10.9
164
958
WX290
NOMESCO Finland
Other blockage of nerve
1.6
10.8
356
2588
L17
ICPC
Foot/toe symptom/complaint
1.7
10.8
278
1899
K03.66
ICD-10 Finland
Tooth plaque
2.4
10.7
78
347
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
3.8
10.7
32
86
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.4
10.6
39
120
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.1
10.6
45
152
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.0
10.2
112
587
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.9
10.2
49
177
S70.0
ICD-10 Finland
Contusion of hip
2.9
10.2
49
177
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.8
10.2
53
200
R13
ICD-10 Finland
Dysphagia
2.3
10.0
82
384
M03BX01
ATC
baclofen; systemic
4.0
9.9
28
72
S20.2
ICD-10 Finland
Contusion of thorax
2.6
9.9
56
221
J01CA08
ATC
pivmecillinam; oral
1.6
9.9
303
2153
A03FA01
ATC
metoclopramide; systemic, rectal
0.4
9.8
68
1399
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
7.5
9.7
22
30
F02.34
ICD-10 Finland
Dementia in Parkinson's disease, other additional symptoms of mixed type
55.6
9.7
11
*
L03
ICPC
Low back symptom/complaint
1.7
9.5
245
1664
IBC97
NOMESCO Finland
Other psychiatric aptitude assessment
101.1
9.4
10
*
S01.8
ICD-10 Finland
Open wound of other parts of head
4.3
9.4
24
57
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
9.4
603
5057
R32
ICD-10 Finland
Unspecified urinary incontinence
3.3
9.4
35
109
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
22.0
9.4
13
6
F05.9
ICD-10 Finland
Delirium, unspecified
3.7
9.3
29
80
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.7
9.3
198
1278
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
9.6
9.3
18
19
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.7
9.2
29
81
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.8
9.1
140
823
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
2.5
9.1
56
231
N86
ICPC
Multiple sclerosis
12.7
8.9
15
12
S62.3
ICD-10 Finland
Fracture of other metacarpal bone
3.5
8.8
30
88
R44.1
ICD-10 Finland
Visual hallucinations
9.1
8.6
17
19
SPAT1167
SPAT
Insertion of urinary catheter
2.8
8.5
43
160
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
4.2
8.5
22
53
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.2
8.4
16
621
G25.0
ICD-10 Finland
Essential tremor
3.0
8.4
36
122
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.8
8.4
43
161
NF1AA
NOMESCO Finland
Hip X-ray examination
2.0
8.4
101
547
K08.3
ICD-10 Finland
Retained dental root
2.1
8.4
80
398
WX402
NOMESCO Finland
General anaesthesia
1.7
8.4
190
1244
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
3.1
8.4
34
112
N87
ICD-10 Finland
Dysplasia of cervix uteri
+∞
8.3
8
*
UDQ42
NOMESCO Finland
Endoscopic assessment of swallowing function
14.6
8.2
13
9
S06.0
ICD-10 Finland
Concussion
1.9
8.2
102
559
L75
ICPC
Fracture: femur
4.4
8.2
20
46
U07
ICPC
Urine symptom/complaint other
2.1
8.1
78
389
WX002
NOMESCO Finland
Sedation and analgesia
1.6
8.1
197
1312
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.7
8.1
42
159
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
8.1
250
1766
Y94.0
ICD-10 Finland
Accident at home
3.9
8.0
23
60
XKD03
NOMESCO Finland
Urethral pressure profilometry
3.3
8.0
30
94
R41.0
ICD-10 Finland
Disorientation, unspecified
2.8
7.9
38
138
M79.6
ICD-10 Finland
Pain in limb
1.5
7.9
367
2832
R4110
NOMESCO Finland
Physiotherapy
1.6
7.8
261
1873
G90.3
ICD-10 Finland
Multi-system degeneration
45.4
7.7
9
*
G23.2
ICD-10 Finland
Multiple system atrophy, parkinsonian type [MSA-P]
45.4
7.7
9
*
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
3.1
7.6
31
102
EBA00
NOMESCO Finland
Extraction of tooth
1.5
7.6
300
2229
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.4
7.6
53
232
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
3.4
7.6
27
82
L84
ICD-10 Finland
Corns and callosities
2.6
7.4
41
160
F02.32
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly hallucinations
80.7
7.4
8
*
F0232, G20,
ICD-10 Finland
80.7
7.4
8
*
SFA20
NOMESCO Finland
Two-surface restoration
1.5
7.4
462
3765
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
3.7
7.3
23
64
N04BX01
ATC
tolcapone; oral
+∞
7.3
7
*
M41.4
ICD-10 Finland
Neuromuscular scoliosis
+∞
7.3
7
*
N06AX21
ATC
duloxetine; oral
1.9
7.3
101
574
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
2.2
7.2
62
297
U02
ICPC
Urinary frequency/urgency
1.7
7.1
130
802
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.3
7.1
50
220
S01.9
ICD-10 Finland
Open wound of head, part unspecified
3.7
7.1
22
61
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.5
7.1
230
1637
SAA02
NOMESCO Finland
Basic examination of mouth
1.5
7.0
514
4299
I10
ICD-10 Finland
Essential (primary) hypertension
0.7
7.0
441
5239
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
0.1
6.9
*
253
M81.0
ICD-10 Finland
Postmenopausal osteoporosis
2.8
6.9
34
125
SFA10
NOMESCO Finland
One-surface restoration
1.5
6.9
438
3563
I95.9
ICD-10 Finland
Hypotension, unspecified
3.3
6.9
25
77
SPAT1139
SPAT
Nutrition survey
2.6
6.9
38
149
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
6.9
383
3039
M01AH05
ATC
etoricoxib; oral
1.5
6.9
520
4371
K04.1
ICD-10 Finland
Necrosis of pulp
1.9
6.8
92
518
M70.6
ICD-10 Finland
Trochanteric bursitis
1.7
6.8
123
756
R1420, ,
SPAT
40.4
6.8
8
*
SCA02
NOMESCO Finland
Preventive oral health care
2.0
6.7
70
361
C10AA07
ATC
rosuvastatin; oral
0.6
6.6
166
2375
N08
ICPC
Abnormal involuntary movements
12.4
6.6
11
9
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.9
6.6
89
501
SPAT1293
SPAT
Other function in accordance with rehabilitation guidance nomenclature
8.8
6.6
13
15
SPAT1125
SPAT
Stoma care and guidance
3.4
6.4
22
65
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
2.1
6.4
60
297
SPAT1262
SPAT
Handing over of treatment supplies
1.6
6.4
170
1153
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
6.4
346
2721
K02
ICD-10 Finland
Dental caries
2.1
6.4
60
298
K56.2
ICD-10 Finland
Volvulus
8.2
6.3
13
16
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
2.4
6.3
42
180
N04AA01
ATC
trihexyphenidyl; oral
+∞
6.3
6
*
AAG99
NOMESCO Finland
Other stereotactic intracranial operation
+∞
6.3
6
*
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
26.9
6.2
8
*
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.8
6.2
31
115
G04CB01
ATC
finasteride; oral
1.7
6.2
121
758
R2110
NOMESCO Finland
Giving the first information
2.2
6.2
50
233
S01
ICD-10 Finland
Open wound of head
4.0
6.2
17
43
WX882
NOMESCO Finland
High dependency care
2.7
6.1
32
122
S72.1
ICD-10 Finland
Pertrochanteric fracture
2.8
6.1
29
105
130
Kela drug reimbursment
Malignant tumour
0.3
6.1
20
573
N99
ICPC
Neurological disease other
3.6
6.1
19
53
ZXY02
NOMESCO Finland
Neuropsychologist
10.1
6.0
11
11
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
6.1
6.0
15
25
SCA03
NOMESCO Finland
Preventive oral health care, extensive
2.5
6.0
36
147
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
43
29
15.53
48.79
1.9
1.2
80.09
132.40
nmol/l
0.68
23
21
674
5208
2.21
22.65
6.5
4.7
4.60
2167.23
e6/l
—
5
81
399
2566
2.01
22.23
2.7
2.2
249.13
235.11
u/l
0.10
379
2407
372
2337
2.02
22.12
3.4
3.4
0.45
0.48
e6/l
0.12
297
1803
442
3037
1.90
19.44
3.3
3.4
—
—
—
0
0
423
2873
1.90
19.21
4.0
4.0
159.94
119.69
e6/l
0.34
317
2111
558
4189
1.89
18.10
4.5
7.1
1.21
1.21
mmol/l
0.52
461
3578
379
2535
1.86
17.61
3.6
3.5
177.48
89.71
e6/l
0.25
294
1987
619
4840
1.92
17.29
4.5
5.0
6.37
6.78
mmol/l
9.24
599
4571
483
3531
1.80
16.37
2.3
2.1
82.91
93.72
pmol/l
7.01
319
1831
504
3751
1.79
15.89
4.7
3.9
0.00
0.00
estimate
0.50
131
746
501
3751
1.77
15.20
6.4
5.3
0.00
0.00
estimate
-0.00
119
701
506
3801
1.77
15.16
4.7
3.9
0.00
0.01
estimate
0.80
121
676
318
2107
1.79
14.57
1.7
1.6
17.44
20.61
nmol/l
4.29
287
1768
262
1666
1.81
13.60
2.0
1.8
1160.29
1202.59
nmol/l
0.33
216
1239
504
3858
1.71
13.41
4.1
6.2
1.21
1.21
mmol/l
0.25
459
3509
165
909
2.00
13.27
4.7
3.3
—
—
—
0
0
528
4127
1.69
12.68
10.3
16.5
1.20
1.30
inr
2.98
176
1136
274
1811
1.74
12.25
1.8
1.7
388.56
14237019.54
pmol/l
1.32
232
1454
434
3253
1.65
12.01
4.9
3.9
35.33
51.30
ng/l
0.76
360
2504
102
503
2.16
10.95
1.4
1.5
—
—
—
0
0
385
2851
1.62
10.83
5.3
4.2
—
—
—
0
0
261
1754
1.69
10.75
2.7
2.7
5.68
4.59
e6/l
0.76
241
1593
228
1484
1.72
10.54
3.0
2.9
1.35
1.04
e6/l
0.40
138
884
180
2706
0.58
9.56
2.8
3.2
7.83
7.47
mmol/l
0.53
143
2233
122
692
1.88
8.83
3.0
3.8
1.22
1.23
mmol/l
0.05
103
602
392
3033
1.52
8.46
2.7
2.8
121.62
158.26
ug/l
3.36
343
2743
283
2043
1.56
8.36
5.1
4.2
0.00
0.01
estimate
0.69
114
666
465
3745
1.51
8.20
2.5
2.7
—
—
—
0
0
102
564
1.91
7.97
1.6
1.7
—
—
—
0
0
208
1426
1.60
7.56
1.8
1.9
—
—
—
0
0
810
7470
1.94
7.48
18.8
16.4
25.07
26.17
mg/l
0.46
699
6031
395
3116
1.48
7.47
2.3
2.2
72.91
79.11
nmol/l
4.50
342
2726
281
2068
1.52
7.45
2.4
2.1
3.02
3.08
mg/l
0.16
223
1741
203
2812
0.64
7.12
3.6
3.8
4.80
8.68
mg/mmol
1.84
134
1759
202
1400
1.57
6.96
3.3
3.1
2.57
2.01
e6/l
0.30
113
802
18
44
4.15
6.84
1.2
1.8
—
—
—
0
0
196
1377
1.54
6.30
2.4
2.0
30.02
29.63
s
0.36
187
1330
275
2080
1.47
6.17
3.7
4.1
87.22
87.13
%
0.02
269
2029
842
7963
2.06
5.79
21.8
19.3
139.98
139.69
mmol/l
3.17
823
7756
754
6919
1.59
5.75
4.7
4.7
1.91
2.20
mu/l
0.93
683
6205
447
3746
1.39
5.46
2.5
2.3
—
—
—
0
0
842
7984
2.01
5.41
21.8
19.5
3.96
3.99
mmol/l
4.37
822
7770
161
2236
0.66
5.40
1.4
1.7
1.20
1.37
mmol/l
2.26
116
1848
641
5722
1.43
5.32
3.5
4.3
10.91
13.52
mm/h
6.05
593
5235
17
49
3.52
5.19
3.1
2.5
—
—
—
0
0
631
5635
1.41
5.08
3.8
3.9
15.27
15.01
pmol/l
1.75
560
5028
144
1001
1.52
4.79
1.6
1.8
—
—
—
0
0
255
1982
1.40
4.73
2.3
2.5
—
—
—
0
0
118
796
1.56
4.49
2.9
3.7
2.97
2.08
mmol/l
2.13
108
669
146
1044
1.48
4.23
3.7
7.3
5.38
5.10
kpa
2.86
140
1001
146
1045
1.48
4.21
3.7
7.3
13.23
11.99
kpa
1.68
140
1004
146
1045
1.48
4.21
3.7
7.4
1.92
1.22
mmol/l
1.38
122
826
428
3657
1.33
4.20
4.6
6.2
24.22
26.81
%
4.93
394
3418
425
3628
1.33
4.20
3.6
5.0
35.32
34.99
g/l
0.61
390
3386
422
3605
1.32
4.12
4.5
6.0
61.12
57.78
%
6.71
392
3374
505
4435
1.32
4.01
5.7
9.5
4.23
4.16
e9/l
0.26
440
3884
216
1675
1.38
3.98
1.9
1.6
1.88
1.36
mg/l
0.85
174
1322
139
1003
1.46
3.84
1.6
1.9
—
—
—
0
0
18
435
0.40
3.83
2.0
1.8
—
—
—
0
0
327
2719
1.32
3.78
2.5
3.0
1015.60
1320.84
ng/l
1.58
282
2344
705
7466
0.73
3.38
3.8
4.8
1.45
1.45
mmol/l
0.01
619
6762
88
595
1.53
3.34
5.7
6.3
25.84
24.48
mmol/l
3.59
83
566
35
184
1.94
3.28
2.1
2.6
16.41
15.88
%
0.22
16
99
44
735
0.58
3.20
1.6
1.7
1.36
1.60
%
2.54
37
605
664
6156
1.31
3.06
5.4
8.1
78.47
79.66
u/l
0.39
611
5766
681
7219
0.76
2.96
3.5
4.3
1.14
1.30
mmol/l
10.64
595
6484
714
7519
0.75
2.96
3.8
4.9
4.48
4.54
mmol/l
0.90
633
6862
733
7686
0.74
2.90
4.3
5.5
2.65
2.65
mmol/l
0.05
643
6984
326
2795
1.26
2.79
2.6
3.6
2.35
2.35
mmol/l
0.00
287
2440
51
317
1.65
2.79
2.0
1.7
—
—
—
0
0
0
73
0.00
2.79
0.0
1.0
—
—
—
0
0
200
1613
1.31
2.77
2.6
3.2
2.45
2.46
mmol/l
0.13
176
1428
16
66
2.45
2.72
2.1
2.0
2.20
2.31
u/field
—
5
26
41
245
1.71
2.61
1.3
1.6
—
—
—
0
0
847
8217
1.64
2.60
27.1
24.3
131.04
134.74
g/l
11.40
832
8072
103
758
1.41
2.58
1.4
3.1
65.40
66.45
g/l
0.82
87
688
8
211
0.37
2.56
1.3
1.3
—
—
—
0
0
105
779
1.39
2.51
2.0
2.2
164.24
139.37
ug/g
0.42
84
620
41
248
1.68
2.51
1.2
1.3
—
—
—
0
0
846
8212
1.61
2.49
26.8
24.3
38.70
39.90
%
5.05
791
7597
58
852
0.66
2.47
1.3
1.3
—
—
—
0
0
846
8214
1.61
2.46
26.9
24.2
244.36
242.68
e9/l
0.34
824
7981
691
7272
0.78
2.46
5.5
6.4
39.60
40.52
mmol/mol
2.10
613
6669
70
989
0.68
2.45
3.1
4.3
2.76
27.42
ug/l
2.17
51
826
846
8216
1.60
2.44
27.0
24.1
4.36
4.45
e12/l
7.16
819
7955
53
345
1.57
2.43
2.0
1.9
—
—
—
0
0
154
1219
1.32
2.43
1.8
2.6
2.39
2.28
g/l
1.43
129
1133
171
1391
1.28
2.21
2.3
3.3
0.83
0.81
mmol/l
1.66
160
1305
178
1465
1.27
2.09
1.2
1.2
1.28
1.39
u/ml
0.06
42
369
49
332
1.50
1.93
2.1
2.2
234.68
494.20
ug/l
0.93
44
314
38
244
1.58
1.90
1.2
1.5
285.80
273.54
ug/g
0.15
22
148
161
1329
1.26
1.85
1.9
2.6
11.73
12.67
umol/l
0.96
139
1239
142
1162
1.26
1.76
1.9
2.6
20.80
22.72
%
0.83
115
983
13
63
2.08
1.60
1.2
1.7
—
—
—
0
0
11
50
2.22
1.57
1.4
1.5
—
—
—
0
0
11
50
2.22
1.57
1.4
1.5
—
—
—
0
0
6
21
2.87
1.50
1.3
1.1
—
—
—
0
0
6
21
2.87
1.50
1.3
1.1
—
—
—
0
0
8
169
0.47
1.47
1.1
1.2
—
—
—
0
0
52
381
1.39
1.42
2.2
3.3
4.43
4.45
pmol/l
0.05
46
327
286
2564
1.17
1.39
2.3
2.5
52.52
92.86
u/l
0.69
262
2354
749
7239
1.22
1.37
17.2
15.4
82.48
75.82
ml/min/173m2
19.78
674
5996
669
6405
1.18
1.34
20.7
19.5
14.65
15.45
%
3.34
659
6292
7
147
0.47
1.33
1.1
1.6
—
—
—
0
0
7
147
0.47
1.33
1.1
1.6
—
—
—
0
0
9
175
0.51
1.29
1.2
1.3
—
—
—
0
0
62
795
0.76
1.26
1.2
1.4
—
—
—
0
0
8
160
0.50
1.25
1.0
1.2
—
8.18
—
0
13
124
1044
1.22
1.22
1.7
2.6
1.50
1.83
%
4.51
105
924
76
605
1.28
1.22
1.8
1.7
—
—
—
0
0
6
129
0.46
1.17
1.0
1.1
—
—
—
0
0
40
292
1.39
1.15
1.4
2.9
38.75
37.46
g/l
0.80
30
257
29
202
1.45
1.08
1.6
1.7
—
—
—
0
0
126
1078
1.20
1.07
6.6
7.7
—
—
—
0
0
45
341
1.34
1.05
1.4
2.9
8.62
10.73
g/l
4.84
35
305
42
315
1.35
1.05
1.4
4.1
53.86
78.74
mg/l
0.58
31
260
8
149
0.53
1.04
1.0
1.2
—
55.37
—
0
12
42
316
1.35
1.03
1.4
4.1
25.58
42.52
mg/l
1.09
31
263
187
1668
1.15
0.96
4.9
4.3
1.02
1.02
kg/l
0.17
35
248
457
4314
1.12
0.96
4.0
6.6
10.75
11.75
umol/l
1.67
436
4091
15
234
0.63
0.95
1.2
1.8
—
—
—
0
0
9
51
1.77
0.94
1.1
1.8
—
—
—
0
0
816
8008
1.23
0.93
8.8
11.6
15.94
25.89
u/l
101.15
743
7696
181
1619
1.15
0.90
4.0
4.1
46.38
318.67
ng/l
6.57
154
1358
101
1172
0.84
0.86
1.2
1.3
5.09
14.72
u/ml
1.42
38
414
11
64
1.73
0.86
1.2
1.7
—
—
—
0
0
27
366
0.73
0.85
3.1
3.5
116.10
4016.36
u/ml
0.78
20
305
8
46
1.75
0.82
1.0
1.6
81.00
84.98
umol/l
—
8
46
14
213
0.65
0.82
1.2
1.4
—
—
—
0
0
8
47
1.71
0.81
1.3
1.3
—
—
—
0
0
8
47
1.71
0.81
1.3
1.3
—
—
—
0
0
40
312
1.30
0.80
1.4
3.3
0.02
1.42
g/l
5.36
28
275
0
26
0.00
0.78
0.0
1.3
—
10.15
—
0
26
0
26
0.00
0.78
0.0
1.3
—
27.00
—
0
19
22
158
1.40
0.75
1.1
1.4
0.71
0.86
nmol/l
0.54
17
130
8
134
0.59
0.73
1.0
1.2
—
—
—
0
0
6
106
0.56
0.73
1.0
1.0
—
—
—
0
0
21
286
0.73
0.71
1.5
1.6
—
103.64
—
0
11
80
687
1.18
0.70
1.6
2.1
385.97
369.65
nmol/l
0.29
75
631
45
365
1.25
0.69
1.4
2.9
3.29
3.57
g/l
1.48
35
330
45
365
1.25
0.69
1.4
2.9
6.86
7.39
g/l
1.88
35
330
45
365
1.25
0.69
1.4
2.9
—
—
—
0
0
7
42
1.67
0.68
1.3
1.5
—
—
—
0
0
7
42
1.67
0.68
1.3
1.5
—
—
—
0
0
110
1240
0.87
0.67
1.2
1.3
20.04
38.96
iu/ml
2.08
29
395
16
226
0.70
0.67
2.7
2.1
98.06
88.34
%
1.28
16
217
739
7536
0.89
0.67
4.4
5.1
5.93
6.05
mmol/l
2.04
648
6778
7
43
1.63
0.67
1.6
1.6
—
—
—
0
0
7
43
1.63
0.67
1.6
1.6
—
—
—
0
0
25
190
1.32
0.63
1.4
1.4
—
—
—
0
0
22
164
1.35
0.63
1.2
1.1
—
7.71
—
0
14
46
380
1.22
0.61
1.7
1.9
1.44
2.05
ug/l
0.28
40
338
76
659
1.17
0.61
2.3
3.9
72.89
92.08
ng/l
1.90
59
571
27
209
1.30
0.61
1.5
1.3
476.19
555.24
mg/l
0.92
27
194
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
7
115
0.61
0.58
1.7
1.3
—
—
—
0
0
6
35
1.72
0.57
1.0
1.2
—
70.00
%
—
0
6
8
54
1.49
0.57
1.5
1.5
—
—
—
0
0
25
194
1.30
0.56
1.3
2.3
123.90
128.35
g/l
0.32
20
147
206
2211
0.91
0.55
1.8
2.9
1951.87
7577.75
umol/l
2.23
168
1892
12
171
0.70
0.55
1.1
1.1
—
—
—
0
0
41
340
1.22
0.54
1.4
3.0
2.93
2.97
g/l
0.09
31
305
28
222
1.27
0.54
1.3
1.2
—
—
—
0
0
28
223
1.26
0.53
1.3
1.2
—
—
—
0
0
9
132
0.68
0.52
1.0
1.1
—
—
—
0
0
6
40
1.50
0.51
1.2
1.1
—
—
—
0
0
31
376
0.82
0.48
1.2
1.2
84.83
121.60
iu/ml
0.32
11
137
100
1103
0.89
0.47
3.6
4.9
35.05
32.43
%
1.64
73
727
72
638
1.14
0.46
3.5
3.0
75.57
59.96
ml/min/173m2
2.04
28
259
5
81
0.62
0.46
1.2
1.5
—
—
—
0
0
5
81
0.62
0.46
1.2
1.5
—
—
—
0
0
5
81
0.62
0.46
1.2
1.5
—
—
—
0
0
11
77
1.43
0.45
1.7
1.3
—
—
—
0
0
68
601
1.14
0.45
1.7
2.3
13.70
12.89
nmol/l
0.37
60
526
19
147
1.30
0.45
1.3
1.6
3.73
6.05
iu/l
—
6
44
5
31
1.62
0.43
1.6
3.2
—
—
—
0
0
5
31
1.62
0.43
1.6
3.2
—
—
—
0
0
12
162
0.74
0.42
1.3
1.4
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
24
195
1.24
0.41
2.2
1.6
—
—
—
0
0
0
17
0.00
0.40
0.0
2.8
—
1.22
—
0
17
5
34
1.47
0.40
1.0
1.6
80.48
55.24
ug/l
—
5
34
20
248
0.80
0.39
1.1
1.5
—
—
—
0
0
354
3411
1.06
0.38
4.8
5.4
2.66
2.90
ug/l
0.23
320
3042
12
89
1.35
0.38
1.2
1.7
—
—
—
0
0
83
755
1.11
0.37
2.4
2.4
32.06
42.29
u/l
0.53
71
639
16
202
0.79
0.37
1.1
1.7
—
—
—
0
0
28
332
0.84
0.37
2.4
2.8
—
—
—
0
0
6
43
1.40
0.35
1.2
1.2
—
—
—
0
0
22
181
1.22
0.34
1.5
1.2
3.00
60.02
e6/l
1.06
17
143
89
817
1.10
0.34
2.0
2.2
0.20
0.21
g/l
0.08
80
761
6
45
1.34
0.34
1.3
1.3
151.28
144.18
pmol/l
—
6
45
22
182
1.21
0.33
1.5
1.2
3.79
3.86
mmol/l
0.13
22
170
14
110
1.28
0.32
1.5
1.5
—
—
—
0
0
7
96
0.73
0.31
1.1
1.1
—
—
—
0
0
88
813
1.09
0.30
2.6
2.6
6.67
7.16
ug/l
0.15
68
723
236
2457
0.95
0.29
2.4
3.3
25.42
34.63
u/l
7.17
212
2326
23
270
0.85
0.29
1.4
1.5
—
—
—
0
0
14
112
1.25
0.28
1.5
1.5
—
—
—
0
0
14
112
1.25
0.28
1.5
1.5
—
—
—
0
0
14
112
1.25
0.28
1.5
1.5
—
—
—
0
0
14
112
1.25
0.28
1.5
1.5
—
—
—
0
0
12
150
0.80
0.27
1.3
1.5
—
—
—
0
0
14
113
1.24
0.26
1.5
1.5
—
—
—
0
0
29
253
1.15
0.26
2.0
1.7
—
—
—
0
0
6
84
0.71
0.24
1.5
2.4
—
—
—
0
0
7
95
0.73
0.22
1.0
1.1
—
—
—
0
0
14
167
0.84
0.21
1.9
2.1
64.18
60.40
%
0.28
14
167
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
21
241
0.87
0.21
1.4
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
7.5
—
6.35
—
0
11
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
12
98
1.23
0.21
1.2
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
8
102
0.78
0.21
8.9
3.7
—
—
—
0
0
18
209
0.86
0.21
1.2
1.6
—
—
—
0
0
18
154
1.17
0.21
1.4
1.8
5.90
4.62
mmol/24h
0.62
13
135
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
6
48
1.25
0.20
1.0
1.0
—
—
—
0
0
6
51
1.18
0.19
1.3
1.5
—
248.33
—
0
6
59
550
1.08
0.19
4.1
3.8
2.24
1.87
mmol/l
0.34
49
425
16
137
1.17
0.19
1.8
1.3
—
—
—
0
0
11
131
0.84
0.17
1.4
1.5
—
—
—
0
0
194
1998
0.96
0.16
3.2
3.2
0.64
0.76
ug/l
2.59
143
1401
282
2760
1.03
0.15
4.1
4.6
20.38
21.18
%
0.50
167
1427
7
88
0.79
0.14
1.1
1.1
121.00
115.16
%
—
7
80
119
1147
1.04
0.14
2.6
5.9
0.98
1.03
mmol/l
1.58
105
1051
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
29
316
0.91
0.14
2.2
2.6
0.39
0.36
u/ml
0.17
19
181
16
180
0.89
0.13
1.3
1.4
—
—
—
0
0
16
180
0.89
0.13
1.3
1.4
—
—
—
0
0
74
772
0.95
0.12
2.8
3.0
175.09
203.95
ng/l
0.37
67
711
10
115
0.87
0.10
1.4
1.5
—
—
—
0
0
107
1038
1.04
0.10
2.2
4.2
233.59
247.93
u/l
0.55
99
977
20
183
1.10
0.10
4.7
3.7
32.25
26.38
mg/l
—
8
116
42
443
0.95
0.10
1.3
1.9
1.57
1.58
g/l
0.04
35
386
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
44
1.14
0.10
1.2
1.2
—
—
—
0
0
5
47
1.06
0.09
2.4
1.5
0.60
4.00
u/field
—
5
33
5
48
1.04
0.09
1.4
1.4
—
—
—
0
0
5
48
1.04
0.09
1.4
1.4
—
—
—
0
0
76
785
0.97
0.08
4.2
7.5
9.34
10.43
mmol/l
0.91
68
749
5
65
0.77
0.08
1.6
1.4
12.80
14.12
u/l
—
5
59
11
98
1.12
0.07
2.6
2.7
—
—
—
0
0
6
70
0.86
0.07
2.2
2.2
—
—
—
0
0
6
73
0.82
0.07
1.2
1.0
886.67
631.12
ng/l
—
6
41
6
73
0.82
0.07
1.2
1.0
26.00
43.87
ng/l
—
6
40
6
73
0.82
0.07
1.2
1.0
242.33
312.57
ng/l
—
6
42
7
85
0.82
0.07
1.0
1.1
—
—
—
0
0
31
295
1.05
0.06
1.0
1.0
—
—
—
0
0
32
305
1.05
0.06
1.3
1.3
—
—
—
0
0
11
121
0.91
0.06
1.4
1.5
—
—
—
0
0
12
130
0.92
0.04
2.3
2.8
3.67
4.38
e9/l
0.62
12
130
19
200
0.95
0.04
3.6
3.5
21.46
1893.95
u/ml
0.86
14
188
13
122
1.07
0.02
1.2
1.6
—
—
—
0
0
13
138
0.94
0.02
2.4
3.2
54.08
58.32
%
0.45
13
138
14
147
0.95
0.01
1.1
1.7
—
—
—
0
0
22
227
0.97
0.01
1.2
1.7
5458.50
15391.94
e6/l
1.63
12
167
91
918
0.99
0.01
1.9
2.8
6.83
8.87
umol/l
0.67
77
814
15
156
0.96
0.00
1.0
1.3
—
—
—
0
0
10
98
1.02
0.00
1.4
1.6
—
—
—
0
0
474
4745
1.00
0.00
2.9
3.3
44.27
55.12
u/l
0.80
428
4360
18
175
1.03
0.00
1.4
1.7
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
1745.20
—
0
5
6
68
0.88
-0.00
1.3
1.3
7.67
10.74
u/l
—
6
61
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
8.0
—
74.80
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
79
0.89
-0.00
1.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
8.41
—
0
9
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
2.60
—
0
5
5
59
0.85
-0.00
1.2
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
28.90
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
6.7
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.7
—
100.89
—
0
9
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: PDMED_RASAGILINE – Use of rasagiline
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).